Site name unknown Daegu

Phase	Trial [desc]	Trial Status	Site Status	Drug	NCT#
3	Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg (LANGIST)	Terminated	Closed	Nilotinib or Imatinib	NCT00751036